Cover Image
市場調查報告書

臨床微生物學市場收益分析:各產品(實驗室設備,微生物學分析設備,試劑),各用途(呼吸系統,血流感染,腸胃,性感染疾病,其他),及市場區隔預測

Clinical Microbiology Market Revenue Analysis By Product (Laboratory Instruments, Microbiology Analyzers, Reagents) By Application, And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 374614
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床微生物學市場收益分析:各產品(實驗室設備,微生物學分析設備,試劑),各用途(呼吸系統,血流感染,腸胃,性感染疾病,其他),及市場區隔預測 Clinical Microbiology Market Revenue Analysis By Product (Laboratory Instruments, Microbiology Analyzers, Reagents) By Application, And Segment Forecasts To 2024
出版日期: 2016年10月04日 內容資訊: 英文 90 Pages
簡介

本報告提供全球臨床微生物學市場相關調查,市場概要和今後預測,彙整各市場區隔及地區別趨勢,及加入此市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場概要

第4章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 滲透與成長預測製圖
  • SWOT分析
  • 產業分析:波特五力分析

第5章 市場類別1:各產品預測與趨勢分析

  • 產品趨勢分析
  • 實驗室設備
  • 微生物學分析設備
  • 試劑

第6章 市場類別2:各用途預測與趨勢分析

  • 用途趨勢分析
  • 呼吸疾病
  • 血流感染
  • 腸胃疾病
  • 性感染疾病
  • 尿道感染
  • 牙周病

第7章 市場類別3:各地區預測及趨勢分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭環境

  • 策略架構
  • 市場進入分類
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-142-9

The global clinical microbiology market was valued at USD 8.4 billion in 2015 and is expected to reach a value of USD 16.1 billion by 2024. Key factors driving the market growth include constant introduction of advanced products coupled with increasing demand in pharmaceutical, and clinical applications for investigation and diagnosis of various infectious diseases.

The market is rapidly growing due to the increasing adoption of automated and advanced technologies for laboratory instruments and analyzers in developed countries. Growing geriatric population and thereby rising prevalence of infectious diseases is one of the major factors boosting the adoption of clinical microbiology in healthcare sector for disease diagnosis and monitoring. In addition, industry is gaining high momentum with launch of innovative products such as MALDI Biotyper, GeneXpert and Myla IT performance management solutions. Moreover, with the U.S. FDA approving the Xpert Carba-R, commercialization of clinical microbiology devices is expected to increase significantly over the next few years.

In North America, the government authorities and private companies have significantly contributed toward technology development, research funding, and commercialization of clinical microbiology associated devices.

Further Key Findings from the Study Suggest:

Rapid adoption of technology and automation of laboratory work flow, laboratory instrument segement is expected to be the fastest growing segment with CAGR of 8.6% over the forecast period.

Reagents is the largest segment with market share of 34.7% in 2015. Repeat purchase of reagents contribute to its growth thus it is the largest growing segment in market.

In 2015, North America dominated the global market with largest revenue share of 41.0%. The continuous research on infectious disease treatment, and subsequent grant from government healthcare agencies are contributing to the development of a strong ecosystem for the expansion of clinical microbiology in the region.

Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing geriatric population in India, China and Japan leading to increase in the prevalence of re-emerging infectious diseases such as tuberculosis, cholera and typhoid in this region are expected to promote the utilization of clinical application of microbiology in healthcare.

The clinical microbiology Industry is presently dominated by a few key participants such as bioMerieux S.A., Cepheid Inc., Danaher Corporation and Bruker Corporation. Some of the prominent players operating in the market include but are not limited to Becton Dickinson & Company, Hologic Inc., Roche Diagnostics and Alere Inc. Introduction of automated systems and innovative designs, is expected to intensify the competition by changing the market dynamics over the forecast period.

Table Of Content

Chapter 1: Research Methodology

  • 1.1. Information procurement
  • 1.2. Data Analysis
  • 1.3. Approaches for market estimation
    • 1.3.1. Approach 1: Demand Analysis & Bottom up Approach
    • 1.3.2. Approach 2: Top down market estimation
    • 1.3.3. Approach 3: Commodity flow and bottom up market estimation
    • 1.3.4. Approach 4: KoL perspective based market sizing

Chapter 2: Executive Summary

Chapter 3: Market Snapshot

Chapter 4: Market Variables, Trends & Scope

  • 4.1. Market segmentation & scope
    • 4.1.1. Market Driver Analysis
      • 4.1.1.1. Demand for automated platform
      • 4.1.1.2. Increasing prevalence of infectious diseases
    • 4.1.2. Market Restraints Analysis
      • 4.1.2.1. Lack of skilled professionals
      • 4.1.2.2. Reimbursement concerns and unfavorable regulatory scenario
  • 4.2. Penetration & growth prospect mapping
  • 4.3. Clinical Microbiology-SWOT Analysis, By Factor(political & legal, economic and technological)
  • 4.4. Industry Analysis-Porter's

Chapter 5: Market Categorization 1: Product Estimates & Trend Analysis

  • 5.1. Clinical Microbiology Market: Product movement analysis
  • 5.2. Laboratory Instruments
    • 5.2.1. Laboratory Instruments Market, 2014-2024(USD Million)
    • 5.2.2. Incubators
    • 5.2.3. Gram Stainers
    • 5.2.4. Bacterial Colony Counters
    • 5.2.5. Autoclave Sterilizers
    • 5.2.6. Petri Dish Fillers
    • 5.2.7. Culture Systems
  • 5.3. Microbiology Analyzers
    • 5.3.1. Microbiology Analyzers market, 2014-2024(USD Million)
    • 5.3.2. Molecular Diagnostics Instruments
    • 5.3.3. Microscopes
    • 5.3.4. Mass Spectrometers
  • 5.4. Reagents
    • 5.4.1. Reagents Market, 2014-2024(USD Million)

Chapter 6: Market Categorization 2: Application Estimates & Trend Analysis

  • 6.1. Clinical Microbiology Market: Disease movement analysis
  • 6.2. Respiratory Diseases
    • 6.2.1. Respiratory Diseases Market, 2014-2024(USD Million)
  • 6.3. Bloodstream Infections
    • 6.3.1. Bloodstream Infections Market, 2014-2024(USD Million)
  • 6.4. Gastrointestinal Diseases
    • 6.4.1. Gastrointestinal Diseases Market, 2014-2024(USD Million)
  • 6.5. Sexually transmitted Diseases
    • 6.5.1. Sexually transmitted Diseases Market, 2014-2024(USD Million)
  • 6.6. Urinary Tract Infections
    • 6.6.1. Urinary Tract Infections Market, 2014-2024(USD Million)
  • 6.7. Periodontal Diseases
    • 6.7.1. Periodontal Diseases Market, 2014-2024(USD Million)

Chapter 7: Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application type

  • 7.1. North America
    • 7.1.1. U.S.
    • 7.1.2. Canada
  • 7.2. Europe
    • 7.2.1. U.K.
    • 7.2.2. Germany
  • 7.3. Asia Pacific
    • 7.3.1. Japan
    • 7.3.2. China
    • 7.3.3. India
  • 7.4. Latin America
    • 7.4.1. Brazil
    • 7.4.2. Mexico
  • 7.5. Middle East and Africa(MEA)
    • 7.5.1. South Africa

Chapter 8: Competitive Landscape

  • 8.1. Market participation categorization
  • 8.2. Company Profiles
    • 8.2.1. bioMerieux S.A.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Abbott Laboratories
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Roche Diagnostics
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Bruker Corporation
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Alere Inc.
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Cepheid Inc.
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Bio-Rad Laboratories Inc.
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Becton Dickinson and Company
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Hologic Inc.
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives

List of Tables

  • TABLE 1: North America Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 2: North America Clinical Microbiology market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 3: North America Clinical Microbiology market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 4: North America Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 5: U.S.Clinical MicrobiologyMarket, by Product, 2014 - 2024 (USD Million)
  • TABLE 6: U.S.Clinical MicrobiologyMarket, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 7: U.S. Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 8: U.S. Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 9: Canada Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 10: Canada Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 11: Canada Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 12: Canada Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 13: Europe Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 14: Europe Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 15: Europe Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 16: Europe Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 17: U.K. Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 18: U.K. Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 19: U.K.Clinical MicrobiologyMarket, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 20: U.K Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 21: Germany Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 22: Germany Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 23: Germany Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 24: Germany Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 25: Asia Pacific Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 26: Asia Pacific Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 27: Asia Pacific Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 28: Asia Pacific Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 29: Japan Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 30: Japan Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 31: Japan Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 32: Japan Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 33: China Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 34: China Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 35: China Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 36: China Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 37: India Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 38: India Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 39: India Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 40: India Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 41: Latin America Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 42: Latin America Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 43: Latin America Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 44: Latin America Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 45: Brazil Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 46: Brazil Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 47: Brazil Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 48: Brazil Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 49: Mexico Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 50: Mexico Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 51: Mexico Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 52: Mexico Clinical Microbiology Market, by Application 2014 - 2024 (USD Million)
  • TABLE 53: MEA Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 54: MEA Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 55: MEA Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 56: MEA Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
  • TABLE 57: South Africa Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
  • TABLE 58: South Africa Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
  • TABLE 59: South Africa Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
  • TABLE 60: South Africa Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Primary research pattern
  • FIG. 4: Market research approaches
  • FIG. 5: Value chain based sizing & forecasting
  • FIG. 6: QFD modelling for market share assessment
  • FIG. 7: Market summary
  • FIG. 8: Market trends & outlook
  • FIG. 9: Market segmentation & scope
  • FIG. 10: Market driver relevance analysis (Current & future impact)
  • FIG. 11: Global Aging Population Demographics, 2015 & 2050
  • FIG. 12: Market driver relevance analysis (Current & future impact)
  • FIG. 13: Penetration & Growth prospect mapping
  • FIG. 14: SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 15: Porter's Five Forces Analysis
  • FIG. 16: Clinical Microbiology market product outlook key takeaways
  • FIG. 17: Clinical Microbiology: Product movement analysis
  • FIG. 18: Laboratory Instruments Market, 2014 - 2024 (USD Million)
  • FIG. 19: Incubators Market, 2014 - 2024 (USD Million)
  • FIG. 20: Gram Stainers Market, 2014 - 2024 (USD Million)
  • FIG. 21: Bacterial Colony CountersMarket, 2014 - 2024 (USD Million)
  • FIG. 22: Autoclave Sterilizers Market, 2014 - 2024 (USD Million)
  • FIG. 23: Petri Dish Fillers Market, 2014 - 2024 (USD Million)
  • FIG. 24: Culture SystemsMarket, 2014 - 2024 (USD Million)
  • FIG. 25: Microbiology Analyzers Market, 2014 - 2024 (USD Million)
  • FIG. 26: Molecular Diagnostics Instruments Market, 2014 - 2024 (USD Million)
  • FIG. 27: Microscopes Market, 2014 - 2024 (USD Million)
  • FIG. 28: Mass Spectrometers Market, 2014 - 2024 (USD Million)
  • FIG. 29: Reagents Market, 2014 - 2024 (USD Million)
  • FIG. 30: Clinical Microbiology market disease outlook key takeaways
  • FIG. 31: Clinical Microbiology: Application movement analysis
  • FIG. 32: Respiratory Diseases Market, 2014 - 2024 (USD Million)
  • FIG. 33: Bloodstream Infections Market, 2014 - 2024 (USD Million)
  • FIG. 34: Gastrointestinal Diseases Market, 2014 - 2024 (USD Million)
  • FIG. 35: Sexually transmitted Diseases Market, 2014 - 2024 (USD Million)
  • FIG. 36: Urinary Tract Infections Market, 2014 - 2024 (USD Million)
  • FIG. 37: Periodontal Diseases Market, 2014 - 2024 (USD Million)
  • FIG. 38: Regional market place: Key takeaways
  • FIG. 39: Strategy framework
  • FIG. 40: Participant categorization
Back to Top